These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18435134)

  • 1. The new Stark Phase II rules.
    Harris JA
    Bull Am Coll Surg; 2004 Jun; 89(6):8-11. PubMed ID: 18435134
    [No Abstract]   [Full Text] [Related]  

  • 2. The new Stark rules: what does Stark II Phase III mean for healthcare providers?
    Hofstra PS; Bilimoria NM
    J Med Pract Manage; 2008; 23(5):300-3. PubMed ID: 18472609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician refer thyself: is Stark II, phase III the final voyage?
    Manchikanti L; McMahon EB
    Pain Physician; 2007 Nov; 10(6):725-41. PubMed ID: 17987094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the new Stark Phase II regulations.
    Siegel S
    Health Care Law Mon; 2004 Jun; ():3-15. PubMed ID: 15250190
    [No Abstract]   [Full Text] [Related]  

  • 5. Final phase of the Stark regulations takes effect: how we got here.
    Edwards C
    Bull Am Coll Surg; 2008 Feb; 93(2):22-5. PubMed ID: 18350995
    [No Abstract]   [Full Text] [Related]  

  • 6. New Stark Phase III Regulations: The Impact and Changes.
    Travis NL; Wool HS; Finnegan JH
    J Am Coll Radiol; 2008 Feb; 5(2):139-43. PubMed ID: 18242531
    [No Abstract]   [Full Text] [Related]  

  • 7. Stark rules. Purchases that pass muster.
    Terry K
    Med Econ; 2006 Dec; 83(24):44-6, 49. PubMed ID: 17249392
    [No Abstract]   [Full Text] [Related]  

  • 8. Stark revisions arrive. Docs await CMS referral changes--whatever they are.
    Blesch G
    Mod Healthc; 2007 Sep; 37(35):8-9. PubMed ID: 17960699
    [No Abstract]   [Full Text] [Related]  

  • 9. Examining the impact of the new Stark rules on joint ventures.
    Washlick JR
    Healthc Financ Manage; 2008 Nov; 62(11):48-52. PubMed ID: 18990836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will relaxing Stark bind you tighter?
    Terry K
    Med Econ; 2006 Feb; 83(3):40-3. PubMed ID: 16506627
    [No Abstract]   [Full Text] [Related]  

  • 11. Stark III: refinement not revolution (part 1).
    Gosfield AG
    Fam Pract Manag; 2008 Mar; 15(3):25-8. PubMed ID: 18422263
    [No Abstract]   [Full Text] [Related]  

  • 12. Buyer beware: complying with amended stark and anti-kickback regulations.
    Klein SR; Fox SJ
    J Healthc Inf Manag; 2008; 22(2):8-10. PubMed ID: 19266987
    [No Abstract]   [Full Text] [Related]  

  • 13. The new Stark rules: a kinder, gentler version?
    Cassidy MA
    Health Care Law Mon; 2001 Mar; ():3-6. PubMed ID: 11291231
    [No Abstract]   [Full Text] [Related]  

  • 14. The Stark Law: boon or boondoggle? An analysis of the prohibition on physician self-referrals.
    Wales SD
    Law Psychol Rev; 2003; 27():1-28. PubMed ID: 16514757
    [No Abstract]   [Full Text] [Related]  

  • 15. What new Stark rules mean for ORs.
    OR Manager; 2004 Jul; 20(7):17. PubMed ID: 15338657
    [No Abstract]   [Full Text] [Related]  

  • 16. CMS shines up its 'shoes'. Stark revisions ease tensions on self-referrals.
    Blesch G
    Mod Healthc; 2008 Aug; 38(34):17. PubMed ID: 18800481
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase I of the Stark II final rule.
    Wachler AB; Avery PA
    Mich Health Hosp; 2001; 37(4):52-3. PubMed ID: 11467128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How the new Stark rules affect you.
    Guglielmo WJ
    Med Econ; 2008 Feb; 85(3):39-42. PubMed ID: 18314820
    [No Abstract]   [Full Text] [Related]  

  • 19. Stark, antikickback laws, and the OR.
    Murphy LS
    OR Manager; 1998 Jun; 14(6):21-3. PubMed ID: 10180036
    [No Abstract]   [Full Text] [Related]  

  • 20. Stark II rules and labs; lab fee rates overhaul.
    Szabo J
    MLO Med Lab Obs; 2002 May; 34(5):60. PubMed ID: 12024704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.